Goodwin Hospice AcademyGet started free

Hospice eligibility · disease-specific

Hospice eligibility: cancer

Advanced cancer is the most common hospice diagnosis and one of the clearest LCD frameworks. Eligibility usually turns on evidence of disease progression, treatment status, and performance decline.

By Goodwin Hospice Academy Editorial Team·Grounded in MAC Neoplastic Disease LCD·Published February 16, 2026

Educational content only. Individual clinicians must confirm current LCD language with their MAC and defer to the hospice medical director for eligibility certification.

Quick criteria

  • Metastatic disease at presentation OR progression from an earlier stage.
  • Refusal, discontinuation, or documented failure of disease-modifying therapy.
  • Palliative Performance Scale (PPS) ≤ 50%.
  • Continued decline despite therapy or ineligibility for further curative therapy.

Documentation example

A composite narrative illustrating how the LCD framework maps to a real hospice admission (identifying details fictionalized):

Patient is a 76-year-old with stage IV pancreatic adenocarcinoma, disease progression on FOLFIRINOX after two lines of therapy, currently PPS 40%, has declined further systemic therapy, weight loss > 10% over 3 months, KPS trending down from 60 to 40 over 8 weeks.

Workflow for a defensible admission

  1. 01Confirm the primary hospice-eligible cancer diagnosis with the treating oncologist.
  2. 02Document treatment status (declined, failed, or completed) with clear reasoning.
  3. 03Record PPS/KPS at admission and at every recertification.
  4. 04Include specific decline indicators from the last 30-60 days — weight loss %, functional loss, pain trajectory.
  5. 05Reference the MAC neoplastic LCD in your certification narrative.

FAQ

Does the cancer need to be terminal in a specific way?
The hospice medical director must certify a life expectancy of six months or less if the disease runs its normal course. Metastatic disease plus documented progression and decline is the most common eligibility profile.
Can a patient still receive chemotherapy on hospice?
Curative-intent chemotherapy is not covered under the Medicare Hospice Benefit for the terminal diagnosis. Palliative-intent chemotherapy that reduces symptoms may be covered when it is part of the plan of care — check with your hospice medical director and MAC guidance.
What PPS score supports hospice eligibility?
The MAC Neoplastic Disease LCD generally supports PPS ≤ 50%. Lower PPS with continued decline strengthens the documentation.
Do we need imaging showing progression?
Recent imaging or biopsy showing progression is strongly supportive but not always required. Documented clinical progression (symptoms, weight loss, functional decline) can support eligibility even without new imaging.

Turn this into a defensible chart.

Use the free Hospice Eligibility Checklist to walk this framework interactively. Copy the paste-ready documentation summary directly into your narrative note.

Open eligibility checklist Benefit Period Calculator

Related conditions

Eligibility

Liver disease (end-stage)

Eligibility

ALS (amyotrophic lateral sclerosis)

Eligibility

Renal failure (end-stage)

Related reading

Article

What is HOPE?

Article

What is Hospice F2F?

Sources

  1. CMS Medicare Coverage Database (MAC Neoplastic Disease LCD)
  2. CMS Medicare Benefit Policy Manual, Ch. 9
  3. 42 CFR §418 — Hospice Conditions of Participation

Educational content only. Not a substitute for your organization’s policies, your medical director’s clinical judgment, or current MAC LCDs.